The Clinical Effect of Bevacizumab Combined with Carboplatin in the Treatment of Ovarian Cancer and Its Influence on Patients' Serum TGF-β1, HDGF and MIF

LUO Qian

doi:10.14033/j.cnki.cfmr.2021.32.010

Home>Articles>The Clinical Effect of Bevacizumab Combined with Carboplatin in the Treatment of Ovarian Cancer and Its Influence on Patients' Serum TGF-β1, HDGF and MIF

DOI: 10.14033/j.cnki.cfmr.2021.32.010

The Clinical Effect of Bevacizumab Combined with Carboplatin in the Treatment of Ovarian Cancer and Its Influence on Patients' Serum TGF-β1, HDGF and MIF

LUO Qian

Machine-generated Keywords：

Publication Date：2021-11-15

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：4( 36-39 )

Chinese and Foreign Medical Research

ISSN：1674-6805

Year, Vol.(Issue)：2021,19(32)